MICHELLE LEMASTER: Open Payments
NPI 1396394920 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,615 in 188 payments from 21 companies in 2025. Trend: 2023 $1,011 · 2024 $2,114 · 2025 $3,615
Food & beverage: $3,615
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 25 | $832 |
| ABBVIE INC. | 50 | $648 |
| Otsuka America Pharmaceutical, Inc. | 26 | $420 |
| Lundbeck LLC | 17 | $245 |
| Vanda Pharmaceuticals Inc. | 10 | $228 |
| Biogen, Inc. | 4 | $185 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $177 |
| Supernus Pharmaceuticals, Inc. | 8 | $153 |
| Janssen Pharmaceuticals, Inc | 7 | $152 |
| Collegium Pharmaceutical, Inc. | 6 | $93 |
Products named: Auvelity, VRAYLAR, REXULTI, ZURZUVAE, HETLIOZ, CAPLYTA, Qelbree, SPRAVATO.
Industry payments across OH — which companies pay providers there.
